Koyfin Home > Directory > Health Care > Illumina Inc > Repurchase of Common Stock

Illumina Inc Repurchase of Common Stock Chart (ILMN)

Illumina Inc annual/quarterly Repurchase of Common Stock from 2000 to 2018.
  • Illumina Inc Repurchase of Common Stock for the quarter ending September 09, 2018 was $-103m a 27.18% decrease of -28m year over year
  • Illumina Inc Repurchase of Common Stock for the last 12 months ending September 09, 2018 was $-422m a 40.52% decrease of -171m year over year
  • Illumina Inc Annual Repurchase of Common Stock for 2017 was $-319m a -9.40% increase of 30m from 2016
  • Illumina Inc Annual Repurchase of Common Stock for 2017 was $-349m a -14.90% increase of 52m from 2016
  • Illumina Inc Annual Repurchase of Common Stock for 2016 was $-401m a 40.85% decrease of -164m from 2015
Other Cash Flow Metrics:
  • Illumina Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $300m a 15.00% increase of 45m year over year
  • Illumina Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $96m a 128.74% increase of 124m year over year
  • Illumina Inc Total Revenue for the quarter ending December 12, 2018 was $867m a 9.80% increase of 85m year over year
View Chart On Koyfin

Quarterly ILMN Repurchase of Common Stock Data

09/2018$-103m
07/2018$-2m
04/2018$-13m
12/2017$-75m
10/2017$-79m
07/2017$-2m
04/2017$-101m
01/2017$-136m
10/2016$-13m
07/2016$-100m

Annual ILMN Repurchase of Common Stock Data

2017$-319m
2017$-349m
2016$-401m
2014$-237m
2013$-50m
2012$-83m
2012$-570m
2011$-44m
2010$-175m
2008$-71m